JP2007508282A - フェノチアジン及びフェノチアジン類似化合物の［１１ｃ］−放射標識方法 - Google Patents

フェノチアジン及びフェノチアジン類似化合物の［１１ｃ］−放射標識方法 Download PDF

Info

Publication number
JP2007508282A
JP2007508282A JP2006530567A JP2006530567A JP2007508282A JP 2007508282 A JP2007508282 A JP 2007508282A JP 2006530567 A JP2006530567 A JP 2006530567A JP 2006530567 A JP2006530567 A JP 2006530567A JP 2007508282 A JP2007508282 A JP 2007508282A
Authority
JP
Japan
Prior art keywords
phenothiazine
ring
compound
independently
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006530567A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007508282A5 (https=
Inventor
シュヴァイガー，ラッツ，エフ．
クレイブ，スチュアート，エー．
ウェルチ，アンドリュー，イー．
シャープ，ピーター，エフ．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Aberdeen filed Critical University of Aberdeen
Publication of JP2007508282A publication Critical patent/JP2007508282A/ja
Publication of JP2007508282A5 publication Critical patent/JP2007508282A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Catalysts (AREA)
JP2006530567A 2003-09-29 2004-09-27 フェノチアジン及びフェノチアジン類似化合物の［１１ｃ］−放射標識方法 Pending JP2007508282A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0322756.8A GB0322756D0 (en) 2003-09-29 2003-09-29 Methods of chemical synthesis
PCT/GB2004/004153 WO2005030676A1 (en) 2003-09-29 2004-09-27 Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds

Publications (2)

Publication Number Publication Date
JP2007508282A true JP2007508282A (ja) 2007-04-05
JP2007508282A5 JP2007508282A5 (https=) 2007-11-08

Family

ID=29287034

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006530567A Pending JP2007508282A (ja) 2003-09-29 2004-09-27 フェノチアジン及びフェノチアジン類似化合物の［１１ｃ］−放射標識方法

Country Status (13)

Country Link
US (1) US20060275209A1 (https=)
EP (1) EP1667947B1 (https=)
JP (1) JP2007508282A (https=)
CN (2) CN101172162A (https=)
AT (1) ATE405533T1 (https=)
AU (1) AU2004276071B2 (https=)
CA (1) CA2540827A1 (https=)
DE (1) DE602004016010D1 (https=)
ES (1) ES2313063T3 (https=)
GB (1) GB0322756D0 (https=)
PL (1) PL1667947T3 (https=)
SI (1) SI1667947T1 (https=)
WO (1) WO2005030676A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017503004A (ja) * 2013-10-31 2017-01-26 ベス・イスラエル・ディーコネス・メディカル・センター，インコーポレイテッド 近赤外蛍光造影バイオイメージング剤及びその使用方法
US11001562B2 (en) 2013-10-31 2021-05-11 Beth Israel Deaconess Medical Center Near-infrared fluorescent nerve contrast agents and methods of use thereof
US12440585B2 (en) 2023-09-12 2025-10-14 Curadel Surgical Innovations, Inc. Zwitterionic metal chelators

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506197D0 (en) 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
GB0100119D0 (en) 2001-01-03 2001-02-14 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB0101049D0 (en) 2001-01-15 2001-02-28 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB0106953D0 (en) 2001-03-20 2001-05-09 Univ Aberdeen Neufofibrillary labels
GB0117326D0 (en) 2001-07-16 2001-09-05 Univ Aberdeen Napthoquinone-type inhibitors of protein aggregation
CN101084204B (zh) 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
MY162640A (en) 2006-03-29 2017-06-30 Wista Lab Ltd Thioninium compounds and their use
PL2004155T3 (pl) 2006-03-29 2018-08-31 Wista Laboratories Ltd. Inhibitory agregacji białek
EP2013191B3 (en) 2006-03-29 2019-02-27 Wista Laboratories Ltd. 3,7-diamino-10h-phenothiazine salts and their use
DK3121169T3 (da) 2006-07-11 2022-02-28 Wista Lab Ltd Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser
CA3027974C (en) 2007-10-03 2022-03-15 Wista Laboratories Ltd. Therapeutic use of diaminophenothiazines
DK3378856T3 (da) 2009-09-24 2020-12-21 Wista Lab Ltd Krystallinske methylthioniniumchlorid-hydrater
US9192611B2 (en) 2010-11-30 2015-11-24 Wista Laboratories Ltd. Formulations comprising methylthioninium chloride
EA025033B1 (ru) 2011-02-11 2016-11-30 Уиста Лэборэтэриз Лтд. Диаминиевые соли фенотиазина и их применение
US20130315825A1 (en) * 2012-05-03 2013-11-28 Washington University Tricyclic heteroaromatic compounds as alpha-synuclein ligands
GB201512678D0 (en) 2015-07-20 2015-08-26 Wista Lab Ltd Methods of chemical synthesis
CN109796465B (zh) * 2017-11-16 2020-07-14 华中科技大学同济医学院附属协和医院 靶向pet显像化合物、包含该化合物的显象剂及其制备方法和用途
US20210011008A1 (en) * 2019-07-09 2021-01-14 Vanderbilt University Amyloid-binding compounds and methods of use thereof
CN115304633B (zh) * 2022-07-20 2023-12-26 山西大学 一种无重原子光动力光敏剂及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000344685A (ja) * 1999-03-26 2000-12-12 Bf Kenkyusho:Kk アズールａ類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物
JP2001089445A (ja) * 1999-09-17 2001-04-03 Seitai Kino Kenkyusho:Kk デメチルラクロプライドの非求核性酸塩およびこれを用いる［ｃ−１１］ラクロプライドの製造法
WO2002075318A2 (en) * 2001-03-20 2002-09-26 The University Court Of The University Of Aberdeen Neurofibrillary labels
WO2002096896A1 (en) * 2001-05-30 2002-12-05 Photopharmica Limited Biologically active methylene blue derivatives

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000344685A (ja) * 1999-03-26 2000-12-12 Bf Kenkyusho:Kk アズールａ類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物
JP2001089445A (ja) * 1999-09-17 2001-04-03 Seitai Kino Kenkyusho:Kk デメチルラクロプライドの非求核性酸塩およびこれを用いる［ｃ−１１］ラクロプライドの製造法
WO2002075318A2 (en) * 2001-03-20 2002-09-26 The University Court Of The University Of Aberdeen Neurofibrillary labels
JP2004537034A (ja) * 2001-03-20 2004-12-09 ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・アバディーン 神経原線維標識
WO2002096896A1 (en) * 2001-05-30 2002-12-05 Photopharmica Limited Biologically active methylene blue derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017503004A (ja) * 2013-10-31 2017-01-26 ベス・イスラエル・ディーコネス・メディカル・センター，インコーポレイテッド 近赤外蛍光造影バイオイメージング剤及びその使用方法
US11001562B2 (en) 2013-10-31 2021-05-11 Beth Israel Deaconess Medical Center Near-infrared fluorescent nerve contrast agents and methods of use thereof
US11077210B2 (en) 2013-10-31 2021-08-03 Beth Israel Deaconess Medical Center Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
JP7023604B2 (ja) 2013-10-31 2022-02-22 ベス・イスラエル・ディーコネス・メディカル・センター，インコーポレイテッド 近赤外蛍光造影バイオイメージング剤及びその使用方法
US12440585B2 (en) 2023-09-12 2025-10-14 Curadel Surgical Innovations, Inc. Zwitterionic metal chelators

Also Published As

Publication number Publication date
SI1667947T1 (sl) 2009-02-28
DE602004016010D1 (de) 2008-10-02
EP1667947A1 (en) 2006-06-14
CN101172162A (zh) 2008-05-07
AU2004276071A1 (en) 2005-04-07
AU2004276071B2 (en) 2011-02-03
CN1886353B (zh) 2010-06-02
ATE405533T1 (de) 2008-09-15
PL1667947T3 (pl) 2009-01-30
ES2313063T3 (es) 2009-03-01
GB0322756D0 (en) 2003-10-29
HK1087394A1 (en) 2006-10-13
EP1667947B1 (en) 2008-08-20
WO2005030676A1 (en) 2005-04-07
CA2540827A1 (en) 2005-04-07
CN1886353A (zh) 2006-12-27
US20060275209A1 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
JP2007508282A (ja) フェノチアジン及びフェノチアジン類似化合物の［１１ｃ］−放射標識方法
US20250222006A1 (en) Methods of synthesis and/or purification of diaminophenothiazinium compounds
ES2409683T3 (es) Procedimientos de síntesis química y purificación de compuestos de diaminofenotiazinio que incluyen cloruro de metiltioninio (CMT)
CA3047849A1 (en) Synthesis of a thiosulfonic acid by a step of periodate mediated oxidative coupling of a thiosulfonic acid with an aniline
HK1087394B (en) Methods of 11c -radiolabelling phenothiazine and pheno thiazine-like compounds
BR122023024801B1 (pt) Métodos para síntese química de compostos de diaminofenotiazínio incluindo cloreto de metiltionínio (mtc)
HK1129675B (en) Methods of synthesis and/or purification of diaminophenothiazinium compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070920

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110215

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110428

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110511

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111018